BOSTAL LLC

An enabling technology based and long acting injectable (LAI) focused specialty pharmaceutical company founded in New Jersey in 2004.


18Mayfield_Bostal

ABOUT US

Bostal LLC (“BL”, formerly AustarPharma), a pharmaceutical company specializing in enabling drug delivery platform technologies. Since its inception, BL has been devoted in enhancing performance and adding value on successful drug products in and to be in the pharmaceutical markets. Founded by Dr. Ron Liu in Edison NJ USA in 2004, the Company is supported by a team of highly experienced professionals. Our management team has an average of over 20 years of experience in the pharmaceutical industry.

Bostal Drug Delivery (“BDD”) founded by Dr. Ron Liu in Guangzhou, China, 2013. 

Read More

OUR GOAL

To be the global leader in long-acting injectables by leveraging proprietary drug delivery technologies to develop high-impact, differentiated LAI products that improve patient outcomes and deliver strong commercial value.

tree
Mission_1

MISSION

To enhance the lives of patients worldwide by developing long-acting injectable therapies that are safer, more effective, and more convenient — powered by cutting-edge drug delivery technologies and scientific excellence.

VISION

To be the world’s most trusted innovator in long-acting injectables, transforming proven molecules into next-generation therapies that redefine treatment standards across multiple therapeutic areas.

Read More
MissionVision_1
CoreValue

CORE VALUES

1. Innovation
We challenge convention through science-driven innovation in drug delivery and formulation.

2. Quality
We are committed to the highest standards in product performance, safety, and manufacturing.

3. Integrity
We uphold transparency, ethics, and accountability in all our partnerships and operations.

4. Patient Focus
Every decision we make centers on improving patient health, adherence, and outcomes.

5. Collaboration
We partner globally to accelerate access to meaningful therapies and expand impact.

6. Execution Excellence
We deliver on our promises with speed, precision, and operational rigor.

WHAT MAKES US SPECIAL

Platform Technology-Driven Innovation

Bostal LLC is powered by proprietary platform technologies that enhance the performance of proven therapies. Our focus is on developing differentiated, long-acting injectable (LAI) formulations that address unmet clinical needs and improve patient outcomes.

Proprietary LAI Platforms

• Zpheres®

Microsphere-based technology that forms biocompatible particles in the micrometer range, enabling stable and extended drug release for long-acting therapeutic effects.

• Geleepot®

In-situ gel-forming depot system designed to deliver drugs in a stable, biocompatible gel matrix at the injection site, supporting controlled and sustained release profiles.

• Kriztols®

A next-generation nano-microcrystal technology engineered to provide flexible release kinetics — from rapid onset to long-acting delivery — tailored to meet diverse and unmet medical needs.


Integrated R&D and GMP Manufacturing

We operate advanced laboratories and commercial manufacturing facilities that have passed multiple cGMP inspections by the U.S. FDA, EU, and other major regulatory agencies. This enables seamless progression from development to global clinical and commercial supply.


OUR PRODUCTS

Bostal develops differentiated long-acting injectable (LAI) formulations by applying proprietary drug delivery technologies to both new and established molecules. With a highly experienced R&D team and integrated development capabilities, we advance high-barrier products from concept to commercialization with speed and precision.

Product Capability

505(b)(2) Product Introduction

new6
SEMAGLUTIDE LAI

A long-acting GLP-1 receptor agonist designed to extend dosing intervals and improve adherence.


new4
Brexpiprazole LAI 1M

A once-monthly antipsychotic formulation under development for sustained symptom control and improved patient outcomes.


new5
Development Pipeline

Our pipeline includes multiple LAI candidates across CNS, metabolic, and other high-value therapeutic areas, creating attractive opportunities for global collaboration and value-sharing partnerships.


WHY CHOOSE US

Bostal is a trusted partner for pharmaceutical companies seeking to co-develop or commercialize advanced LAI therapies built on enabling platform technologies.
  • Strategic Partnerships
    We collaborate with global partners to unlock the full potential of high-value LAI products through shared innovation, development, and commercialization.
  • Regulatory and IP Expertise
    Our deep knowledge of U.S. regulatory pathways and formulation-based patent strategies ensures competitive positioning and long-term value.
  • Execution Excellence
    From early development to commercial manufacturing, our integrated operations ensure quality, speed, and compliance at every stage.
  • Innovation-Driven Growth
    We focus on technically advanced products that meet real-world clinical needs and deliver meaningful market differentiation.
  • Experienced Team
    Led by industry veterans, our multidisciplinary team brings scientific depth and executional rigor to every collaboration.
Operational Excellence

Optimizing processes to deliver high quality, efficient, and compliant pharmaceutical solutions.

Continuous Growth

Committed to innovation, quality, and continuous progress in delivering advanced pharmaceutical solutions.

Team of experts

We focused on advancing pharmaceutical solutions through innovative approaches and precise execution.

1+
Total Employees
1%
EMPLOYEES wITH MASTER oR Ph.D. dEGREES
1+
R&D Employess
1+
Years of experience